과제정보
The authors thank Medical Illustration & Design, part of the Medical Research Support Services of Yonsei University College of Medicine, for all artistic support related to this work.
참고문헌
- Karpman D, Stahl AL and Arvidsson I (2017) Extracellular vesicles in renal disease. Nat Rev Nephrol 13, 545-562 https://doi.org/10.1038/nrneph.2017.98
- Lipschutz JH (2019) The role of the exocyst in renal ciliogenesis, cystogenesis, tubulogenesis, and development. Kidney Res Clin Pract 38, 260-266 https://doi.org/10.23876/j.krcp.19.050
- Lee SA, Choi C and Yoo TH (2021) Extracellular vesicles in kidneys and their clinical potential in renal diseases. Kidney Res Clin Pract 40, 194-207 https://doi.org/10.23876/j.krcp.20.209
- Linxweiler J and Junker K (2020) Extracellular vesicles in urological malignancies: an update. Nat Rev Urol 17, 11-27 https://doi.org/10.1038/s41585-019-0261-8
- Jing H, Tang S, Lin S, Liao M, Chen H and Zhou J (2019) The role of extracellular vesicles in renal fibrosis. Cell Death Dis 10, 367 https://doi.org/10.1038/s41419-019-1605-2
- Behrens F, Holle J, Kuebler WM and Simmons S (2020) Extracellular vesicles as regulators of kidney function and disease. Intensive Care Med Exp 8, 22 https://doi.org/10.1186/s40635-020-00306-2
- Xu M, Yang Q, Sun X and Wang Y (2020) Recent advancements in the loading and modification of therapeutic exosomes. Front Bioeng Biotechnol 8, 586130 https://doi.org/10.3389/fbioe.2020.586130
- Bochon B, Kozubska M, Surygala G et al (2019) Mesenchymal stem cells-potential applications in kidney diseases. Int J Mol Sci 20, 2462 https://doi.org/10.3390/ijms20102462
- Chen W, Yan Y, Song C, Ding Y and Du T (2017) Microvesicles derived from human Wharton's Jelly mesenchymal stem cells ameliorate ischemia-reperfusion-induced renal fibrosis by releasing from G2/M cell cycle arrest. Biochem J 474, 4207-4218 https://doi.org/10.1042/BCJ20170682
- Zhang G, Zou X, Miao S et al (2014) The anti-oxidative role of micro-vesicles derived from human Wharton-Jelly mesenchymal stromal cells through NOX2/gp91(phox) suppression in alleviating renal ischemia-reperfusion injury in rats. PLoS One 9, e92129 https://doi.org/10.1371/journal.pone.0092129
- Li X, Liao J, Su X et al (2020) Human urine-derived stem cells protect against renal ischemia/reperfusion injury in a rat model via exosomal miR-146a-5p which targets IRAK1. Theranostics 10, 9561-9578 https://doi.org/10.7150/thno.42153
- Zhu G, Pei L, Lin F et al (2019) Exosomes from humanbone-marrow-derived mesenchymal stem cells protect against renal ischemia/reperfusion injury via transferring miR-199a-3p. J Cell Physiol 234, 23736-23749 https://doi.org/10.1002/jcp.28941
- Pan T, Jia P, Chen N et al (2019) Delayed remote ischemic preconditioning confers renoprotection against septic acute kidney injury via exosomal miR-21. Theranostics 9, 405-423 https://doi.org/10.7150/thno.29832
- Grange C, Papadimitriou E, Dimuccio V et al (2020) Urinary extracellular vesicles carrying Klotho improve the recovery of renal function in an acute tubular injury model. Mol Ther 28, 490-502 https://doi.org/10.1016/j.ymthe.2019.11.013
- Christov M, Neyra JA, Gupta S and Leaf DE (2019) Fibroblast growth factor 23 and Klotho in AKI. Semin Nephrol 39, 57-75 https://doi.org/10.1016/j.semnephrol.2018.10.005
- Dominguez JM 2nd, Dominguez JH, Xie D and Kelly KJ (2018) Human extracellular microvesicles from renal tubules reverse kidney ischemia-reperfusion injury in rats. PLoS One 13, e0202550 https://doi.org/10.1371/journal.pone.0202550
- Brigstock DR (2021) Extracellular vesicles in organ fibrosis: mechanisms, therapies, and diagnostics. Cells 10, 1596 https://doi.org/10.3390/cells10071596
- Ebrahim N, Ahmed IA, Hussien NI et al (2018) Mesenchymal stem cell-derived exosomes ameliorated diabetic nephropathy by autophagy induction through the mTOR signaling pathway. Cells 7, 226 https://doi.org/10.3390/cells7120226
- Nagaishi K, Mizue Y, Chikenji T et al (2016) Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes. Sci Rep 6, 34842 https://doi.org/10.1038/srep34842
- Lindoso RS, Lopes JA, Binato R et al (2020) Adipose mesenchymal cells-derived EVs alleviate DOCA-salt-induced hypertension by promoting cardio-renal protection. Mol Ther Methods Clin Dev 16, 63-77 https://doi.org/10.1016/j.omtm.2019.11.002
- Cambier L, Giani JF, Liu W et al (2018) Angiotensin II-induced end-organ damage in mice is attenuated by human exosomes and by an exosomal Y RNA fragment. Hypertension 72, 370-380 https://doi.org/10.1161/HYPERTENSIONAHA.118.11239
- Cantaluppi V, Medica D, Mannari C et al (2015) Endothelial progenitor cell-derived extracellular vesicles protect from complement-mediated mesangial injury in experimental anti-Thy1.1 glomerulonephritis. Nephrol Dial Transplant 30, 410-422 https://doi.org/10.1093/ndt/gfu364
- Eirin A, Zhu XY, Puranik AS et al (2017) Mesenchymal stem cell-derived extracellular vesicles attenuate kidney inflammation. Kidney Int 92, 114-124 https://doi.org/10.1016/j.kint.2016.12.023
- Song T, Eirin A, Zhu X et al (2020) Mesenchymal stem cell-derived extracellular vesicles induce regulatory t cells to ameliorate chronic kidney injury. Hypertension 75, 1223-1232 https://doi.org/10.1161/hypertensionaha.119.14546
- Quaglia M, Dellepiane S, Guglielmetti G, Merlotti G, Castellano G and Cantaluppi V (2020) Extracellular vesicles as mediators of cellular crosstalk between immune system and kidney graft. Front Immunol 11, 74 https://doi.org/10.3389/fimmu.2020.00074
- Yu X, Huang C, Song B et al (2013) CD4+CD25+ regulatory T cells-derived exosomes prolonged kidney allograft survival in a rat model. Cell Immunol 285, 62-68 https://doi.org/10.1016/j.cellimm.2013.06.010
- Pang XL, Wang ZG, Liu L et al (2019) Immature dendritic cells derived exosomes promotes immune tolerance by regulating T cell differentiation in renal transplantation. Aging (Albany NY) 11, 8911-8924 https://doi.org/10.18632/aging.102346
- Wu X, Yan T, Wang Z et al (2018) Micro-vesicles derived from human Wharton's Jelly mesenchymal stromal cells mitigate renal ischemia-reperfusion injury in rats after cardiac death renal transplantation. J Cell Biochem 119, 1879-1888 https://doi.org/10.1002/jcb.26348
- Nomura S, Takahashi N, Inami N et al (2004) Probucol and ticlopidine: effect on platelet and monocyte activation markers in hyperlipidemic patients with and without type 2 diabetes. Atherosclerosis 174, 329-335 https://doi.org/10.1016/j.atherosclerosis.2004.01.027
- Nomura S, Inami N, Shouzu A et al (2009) The effects of pitavastatin, eicosapentaenoic acid and combined therapy on platelet-derived microparticles and adiponectin in hyperlipidemic, diabetic patients. Platelets 20, 16-22 https://doi.org/10.1080/09537100802409921
- Dasgupta SK, Le A, Chavakis T, Rumbaut RE and Thiagarajan P (2012) Developmental endothelial locus-1 (Del-1) mediates clearance of platelet microparticles by the endothelium. Circulation 125, 1664-1672 https://doi.org/10.1161/CIRCULATIONAHA.111.068833
- Mossberg M, Stahl AL, Kahn R et al (2017) C1-inhibitor decreases the release of vasculitis-like chemotactic endothelial microvesicles. J Am Soc Nephrol 28, 2472-2481 https://doi.org/10.1681/ASN.2016060637
- Liu X, Miao J, Wang C et al (2020) Tubule-derived exosomes play a central role in fibroblast activation and kidney fibrosis. Kidney Int 97, 1181-1195 https://doi.org/10.1016/j.kint.2019.11.026
- Borges FT, Reis LA and Schor N (2013) Extracellular vesicles: structure, function, and potential clinical uses in renal diseases. Braz J Med Biol Res 46, 824-830 https://doi.org/10.1590/1414-431X20132964
- Jiang XC and Gao JQ (2017) Exosomes as novel bio-carriers for gene and drug delivery. Int J Pharm 521, 167-175 https://doi.org/10.1016/j.ijpharm.2017.02.038
- Kato M (2018) Noncoding RNAs as therapeutic targets in early stage diabetic kidney disease. Kidney Res Clin Pract 37, 197-209 https://doi.org/10.23876/j.krcp.2018.37.3.197
- Tang TT, Lv LL, Wang B et al (2019) Employing macrophage-derived microvesicle for kidney-targeted delivery of dexamethasone: an efficient therapeutic strategy against renal inflammation and fibrosis. Theranostics 9, 4740-4755 https://doi.org/10.7150/thno.33520
- Yim N, Ryu SW, Choi K et al (2016) Exosome engineering for efficient intracellular delivery of soluble proteins using optically reversible protein-protein interaction module. Nat Commun 7, 12277 https://doi.org/10.1038/ncomms12277
- Choi H, Kim Y, Mirzaaghasi A et al (2020) Exosome-based delivery of super-repressor IκBα relieves sepsis-associated organ damage and mortality. Sci Adv 6, eaaz6980 https://doi.org/10.1126/sciadv.aaz6980
- Kim S, Lee SA, Yoon H et al (2021) Exosome-based delivery of super-repressor IκBα ameliorates kidney ischemia-reperfusion injury. Kidney Int 100, 570-584 https://doi.org/10.1016/j.kint.2021.04.039
- Wang B, Yao K, Huuskes BM et al (2016) Mesenchymal stem cells deliver exogenous microRNA-let7c via exosomes to attenuate renal fibrosis. Mol Ther 24, 1290-1301 https://doi.org/10.1038/mt.2016.90
- Zhang A, Wang H, Wang B, Yuan Y, Klein JD and Wang XH (2019) Exogenous miR-26a suppresses muscle wasting and renal fibrosis in obstructive kidney disease. FASEB J 33, 13590-13601 https://doi.org/10.1096/fj.201900884R
- Wang H, Wang B, Zhang A et al (2019) Exosome-mediated miR-29 transfer reduces muscle atrophy and kidney fibrosis in mice. Mol Ther 27, 571-583 https://doi.org/10.1016/j.ymthe.2019.01.008
- Gu D, Zou X, Ju G, Zhang G, Bao E and Zhu Y (2016) Mesenchymal stromal cells derived extracellular vesicles ameliorate acute renal ischemia reperfusion injury by inhibition of mitochondrial fission through miR-30. Stem Cells Int 2016, 2093940
- Ju GQ, Cheng J, Zhong L et al (2015) Microvesicles derived from human umbilical cord mesenchymal stem cells facilitate tubular epithelial cell dedifferentiation and growth via hepatocyte growth factor induction. PLoS One 10, e0121534 https://doi.org/10.1371/journal.pone.0121534
- Du T, Zhou J, Chen WX et al (2020) Microvesicles derived from human umbilical cord mesenchymal stem cells ameliorate renal ischemia-reperfusion injury via delivery of miR-21. Cell Cycle 19, 1285-1297 https://doi.org/10.1080/15384101.2020.1748940
- Collino F, Lopes JA, Correa S et al (2019) Adipose-derived mesenchymal stromal cells under hypoxia: changes in extracellular vesicles secretion and improvement of renal recovery after ischemic injury. Cell Physiol Biochem 52, 1463-1483
- Xiang E, Han B, Zhang Q et al (2020) Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis. Stem Cell Res Ther 11, 336 https://doi.org/10.1186/s13287-020-01852-y
- Grange C, Tritta S, Tapparo M et al (2019) Stem cell-derived extracellular vesicles inhibit and revert fibrosis progression in a mouse model of diabetic nephropathy. Sci Rep 9, 4468 https://doi.org/10.1038/s41598-019-41100-9
- Nassar W, El-Ansary M, Sabry D et al (2016) Umbilical cord mesenchymal stem cells derived extracellular vesicles can safely ameliorate the progression of chronic kidney diseases. Biomater Res 20, 21 https://doi.org/10.1186/s40824-016-0068-0
- Jin J, Qian F, Zheng D, He W, Gong J and He Q (2021) Mesenchymal stem cells attenuate renal fibrosis via exosomes-mediated delivery of microRNA Let-7i-5p antagomir. Int J Nanomedicine 16, 3565-3578 https://doi.org/10.2147/IJN.S299969
- Du T, Ju G, Zhou J et al (2021) Microvesicles derived from human umbilical cord mesenchyme promote M2 macrophage polarization and ameliorate renal fibrosis following partial nephrectomy via hepatocyte growth factor. Hum Cell 34, 1103-1113 https://doi.org/10.1007/s13577-021-00525-z
- Chen L, Wang Y, Li S et al (2020) Exosomes derived from GDNF-modified human adipose mesenchymal stem cells ameliorate peritubular capillary loss in tubulointerstitial fibrosis by activating the SIRT1/eNOS signaling pathway. Theranostics 10, 9425-9442 https://doi.org/10.7150/thno.43315